Delivery Order SPE2DB24D3013-SPE2DB25FFLAJ

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,098.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of 4,568,076,308 units of Metoprolol Succinate Extended-Release 100 mg Tablets. The contract has a performance period extending through April 30, 2025 and is priced on a firm-fixed-price basis. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,565,802,734 units of Metoprolol Succinate Extended-Release 100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,308.84 and a period of performance through September 16, 2024. AmerisourceBergen, a for-profit organization, is not subject to any set-aside requirements for this award. The company...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,878,450 tablets of Metoprolol Succinate Extended-Release 50 mg. The contract has a ceiling value of $1,571.76 and a completion date of May 10, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,862.93, is for the delivery of Metoprolol Succinate Extended-Release Tablets in quantities of 1,000. The contract has an ultimate completion date of March 6, 2024 and is a firm-fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,000 units of Metoprolol Succinate Extended-Release 25 mg tablets, a medication used to treat high blood pressure and heart conditions. The contract has a firm fixed price of $2,529.66 and a period of performance ending on April 23, 2025. The contract is not a set-aside and was awarded on April 22, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the medication Metoprolol Succinate Extended-Release 100 mg tablets. The contract has a firm fixed price of $5,030.32 and a completion date of May 23, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of 4,560,483,611 units of Metoprolol Succinate Extended-Release 100 mg tablets in quantities of 1,000 units per bottle. The contract, valued at $1,979.28, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of April 5, 2023. The contract does not...
This is a $1,785.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for Metoprolol Succinate Extended-Release 25 mg tablets, with an ultimate completion date of June 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a $2,981.75 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract is for the provision of 4,564,389,883 units of the pharmaceutical product Metoprolol Succinate Extended-Release 100 mg Tablets. The order is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical. Under...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Metoprolol Succinate Extended-Release 100 mg Tablets. The award, with a ceiling value of $1,947.80, was made by the Defense Logistics Agency (DLA) Troop Support Medical on June 18, 2024, with a completion date of June 20, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. In addition to this specific award, Amerisourcebergen holds a...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFLAJ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,968,065 units of Metoprolol Succinate Extended-Release 100 mg tablets, a medication used to treat high blood pressure and certain types of chest pain. The contract has a ceiling value of $1,497.19 and a period of performance through April 21, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely part of the larger IDC, allowing the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/18/25, 9:47 AM